145 related articles for article (PubMed ID: 25426555)
1. Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas.
Landuzzi L; Ianzano ML; Nicoletti G; Palladini A; Grosso V; Ranieri D; Dall'Ora M; Raschi E; Laranga R; Gambarotti M; Picci P; De Giovanni C; Nanni P; Lollini PL
Oncotarget; 2014 Dec; 5(23):11924-38. PubMed ID: 25426555
[TBL] [Abstract][Full Text] [Related]
2. Development of spontaneous mammary tumors in BALB/c p53 heterozygous mice. A model for Li-Fraumeni syndrome.
Kuperwasser C; Hurlbut GD; Kittrell FS; Dickinson ES; Laucirica R; Medina D; Naber SP; Jerry DJ
Am J Pathol; 2000 Dec; 157(6):2151-9. PubMed ID: 11106587
[TBL] [Abstract][Full Text] [Related]
3. The p53 inhibitor Mdm4 cooperates with multiple genetic lesions in tumourigenesis.
Xiong S; Pant V; Zhang Y; Aryal NK; You MJ; Kusewitt D; Lozano G
J Pathol; 2017 Mar; 241(4):501-510. PubMed ID: 27925213
[TBL] [Abstract][Full Text] [Related]
4. Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors.
Min JN; Huang L; Zimonjic DB; Moskophidis D; Mivechi NF
Oncogene; 2007 Aug; 26(35):5086-97. PubMed ID: 17310987
[TBL] [Abstract][Full Text] [Related]
5. FasL deficiency enhances the development of tumors in p53+/- mice.
Embree-Ku M; Boekelheide K
Toxicol Pathol; 2002; 30(6):705-13. PubMed ID: 12512872
[TBL] [Abstract][Full Text] [Related]
6. Impact of ionizing radiation and genetic background on mammary tumorigenesis in p53-deficient mice.
Backlund MG; Trasti SL; Backlund DC; Cressman VL; Godfrey V; Koller BH
Cancer Res; 2001 Sep; 61(17):6577-82. PubMed ID: 11522657
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p53 and scid genes do not cooperate in lymphomagenesis in doubly heterozygous mice.
Kosugi S; Miyazawa T; Chou D; Saito Y; Shinbo T; Matsuki A; Okano H; Miyaji C; Watanabe H; Hatakeyama K; Niwa O; Kominami R
Biochem Biophys Res Commun; 1999 Feb; 255(1):99-103. PubMed ID: 10082662
[TBL] [Abstract][Full Text] [Related]
8. Preferential induction of mammary tumors in p53 hemizygous BALB/c mice by fractionated irradiation of a sub-lethal dose of X-rays.
Mori N; Yamate J; Umesako S; Hong DP; Okumoto M; Nakao R
J Radiat Res; 2003 Sep; 44(3):249-54. PubMed ID: 14646229
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of aberrant Y chromosomes in gamma-ray-induced thymic lymphomas lacking p53.
Chou D; Matsuki J; Saitou Y; Kosugi SI; Shinbo T; Gejyo F; Niwa O; Kominami R
Mol Carcinog; 1999 Nov; 26(3):157-62. PubMed ID: 10559790
[TBL] [Abstract][Full Text] [Related]
10. Polμ deficiency induces moderate shortening of P53
Escudero B; Herrero D; Torres Y; Cañón S; Molina A; Carmona RM; Suela J; Blanco L; Samper E; Bernad A
DNA Repair (Amst); 2017 Jun; 54():40-45. PubMed ID: 28460268
[TBL] [Abstract][Full Text] [Related]
11. Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
Umesako S; Fujisawa K; Iiga S; Mori N; Takahashi M; Hong DP; Song CW; Haga S; Imai S; Niwa O; Okumoto M
Breast Cancer Res; 2005; 7(1):R164-70. PubMed ID: 15642165
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice.
Ianzano ML; Croci S; Nicoletti G; Palladini A; Landuzzi L; Grosso V; Ranieri D; Dall'Ora M; Santeramo I; Urbini M; De Giovanni C; Lollini PL; Nanni P
Oncotarget; 2014 Jan; 5(1):108-19. PubMed ID: 24334679
[TBL] [Abstract][Full Text] [Related]
13. Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis.
Hansen SA; Hart ML; Busi S; Parker T; Goerndt A; Jones K; Amos-Landgraf JM; Bryda EC
Dis Model Mech; 2016 Oct; 9(10):1139-1146. PubMed ID: 27528400
[TBL] [Abstract][Full Text] [Related]
14. Tumor spectrum in ARF-deficient mice.
Kamijo T; Bodner S; van de Kamp E; Randle DH; Sherr CJ
Cancer Res; 1999 May; 59(9):2217-22. PubMed ID: 10232611
[TBL] [Abstract][Full Text] [Related]
15. Functional interplay of p53 and Mus81 in DNA damage responses and cancer.
Pamidi A; Cardoso R; Hakem A; Matysiak-Zablocki E; Poonepalli A; Tamblyn L; Perez-Ordonez B; Hande MP; Sanchez O; Hakem R
Cancer Res; 2007 Sep; 67(18):8527-35. PubMed ID: 17875692
[TBL] [Abstract][Full Text] [Related]
16. Genetic interactions between the Wilms' tumor 1 gene and the p53 gene.
Menke AL; Clarke AR; Leitch A; Ijpenberg A; Williamson KA; Spraggon L; Harrison DJ; Hastie ND
Cancer Res; 2002 Nov; 62(22):6615-20. PubMed ID: 12438257
[TBL] [Abstract][Full Text] [Related]
17. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
18. Genetic background influences timing, morphology and dissemination of lymphomas in p53-deficient mice.
van Meyel DJ; Sanchez-Sweatman OH; Kerkvliet N; Stitt L; Ramsay DA; Khokha R; Chambers AF; Cairncross JG
Int J Oncol; 1998 Nov; 13(5):917-22. PubMed ID: 9772279
[TBL] [Abstract][Full Text] [Related]
19. Diet and cancer prevention studies in p53-deficient mice.
Hursting SD; Perkins SN; Phang JM; Barrett JC
J Nutr; 2001 Nov; 131(11 Suppl):3092S-4S. PubMed ID: 11694654
[TBL] [Abstract][Full Text] [Related]
20. Lysine-specific demethylase 1 accelerates oncogenesis in p53 heterozygous mice via transcriptional repression of the residual Trp53 allele.
Wada T; Kikuchi J; Koyama D; Honda H; Furukawa Y
Leuk Res; 2019 Jul; 82():29-32. PubMed ID: 31152920
[No Abstract] [Full Text] [Related]
[Next] [New Search]
